Genome editing to reframe DMD by CRISPR-mediated nonhomologous end joining has been demonstrated as an effective approach for rescuing the expression of functional truncated dystrophin, and it has been shown to result in conversion of DMD to a BMD-like phenotype. This evidence concerns the gene DMD and Becker muscular dystrophy.